Sarepta Therapeutics Inc
SRPT
$17.44-2.30%
End of day · as of Oct 13, 2026, 2:00 AM ET
Mkt cap
$2.34B
EV/Sales
N/A
P/E ratio
N/A
Revenue (qtr ended 2026-06-30)
$401.25M
EPS (H1 2026)
$2.99
Gross Margin (qtr ended 2026-06-30)
N/A
Profit Margin (qtr ended 2026-06-30)
-1.22%
Beta
0.48
Div yield
N/A
Sector
Healthcare
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported SRPT revenue for 2026-06-30 was $401.3M. Net income was -$4.9M. Revenue was down 45.1% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
Use this SRPT research hub for sector, financials, and filings — not a live tape.
Each line names its own latest cached period. Full SRPT income, balance, and cash tables.
† Total Debt (Q2 2026): Derived from long-term debt only (no total or short-term debt stored).
Sarepta Therapeutics Inc (SRPT) is a biotechnology company in the Healthcare sector.
Latest cached Sarepta Therapeutics Inc (SRPT) revenue for Jun 30, 2026 was $401.3M. Net income was -$4.9M. Statements: https://lician.com/financials/srpt
Sarepta Therapeutics Inc (SRPT) market capitalization is $2.34B on the latest cached snapshot.
Sarepta Therapeutics Inc (SRPT) cached previous close $17.85; day range $17.44 – $17.88; volume 3,235,243. Session quote: https://lician.com/quote/srpt
Sarepta Therapeutics Inc (SRPT) latest cached earnings event is "SRPT earnings" on Aug 5, 2026. Earnings calendar: https://lician.com/earnings
The latest cached SRPT filing is 8-K · Sep 23, 2026. Filings: https://lician.com/sec/srpt